3650 results for «512»

Filter By

3650 results

Taking the next step in the evolution of aortic regurgitation treatment

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Explore the latest in aortic regurgitation treatment, including a TAVI case with the Trilogy device, imaging challenges, and future advancements like CMR and guideline updates.

Taking the next step in the evolution of aortic regurgitation treatment

Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...

Imaging strategies for optimal valve selection and outcomes in TAVI

Mastering mitral valve disease: diagnosis, management, and intervention

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

Mastering mitral valve disease: diagnosis, management, and intervention

TAVI in small annulus - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 79-year-old female with CAD (stenosis in the mid-LAD), asthma, and diabetes presented with symptomatic severe aortic stenosis. Left ventricular function was preserved, with an annulus measuring 355 mm², and the valves were heavily calcified.

A Navitor Vision valve was implanted with predilatation (18 mm balloon) under...

TAVI in small annulus - LIVE case

Lifetime management

08 Feb 2025 – From PCR Tokyo Valves 2025

This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...

Lifetime management

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

08 Feb 2025 – From PCR Tokyo Valves 2025

This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

High-risk TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...

High-risk TAVI

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

Mitral valve-in-valve and valve-in-ring electrosurgery

08 Feb 2025 – From PCR Tokyo Valves 2025

Mitral valve-in-valve and valve-in-ring electrosurgery

Redo mitral procedures

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to gain insights into the management of recurrent mitral regurgitation after percutaneous mitral valve interventions. Discover various redo procedures, including the use of the PASCAL system for recurrent MR after MitraClip, redo M-TEER for torn posterior leaflet, and successful redo TEER and MitraClip...

Redo mitral procedures

Future devices for structural heart interventions

08 Feb 2025 – From PCR Tokyo Valves 2025

Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.

Future devices for structural heart interventions

TAV-in-TAV cases

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to delve into the complexities and challenges of TAV-in-TAV procedures. Gain insights into various case studies, including a successful TAV-in-TAV with coronary protection, a case of CABG and TAV-in-TAV, TAVI in a patient with failed homograft and three previous sternotomies, and concurrent mitral...

TAV-in-TAV cases

Nightmare in TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...

Nightmare in TAVI

Standardised implant technique with self-expandable valve

08 Feb 2025 – From PCR Tokyo Valves 2025

Don’t miss this PCR Tokyo Valves 2025 session replay, where leading experts share key techniques for simplifying and optimising TAVI procedures with the Evolut device. This session covers essential insights into safely performing procedures on patients with various anatomical types using the self-expandable valve, while emphasising...

Standardised implant technique with self-expandable valve

M-TEER for secondary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.

M-TEER for secondary mitral regurgitation

How to optimise clinical outcomes with the latest generation intra-annular self-expandable TAVI device?

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the latest advancements in TAVI procedures with this PCR Tokyo Valves 2025 session replay, where leading experts share key strategies to enhance patient outcomes. This session explores how to select the optimal index valve for lifetime management, reduce pacemaker rates with the latest intra-annular self-expanding...

How to optimise clinical outcomes with the latest generation intra-annular self-expandable TAVI device?

Mitral complications

08 Feb 2025 – From PCR Tokyo Valves 2025

Mitral complications

Lifetime management - First valve choice matters

08 Feb 2025 – From PCR Tokyo Valves 2025

In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.

Lifetime management - First valve choice matters
Didn’t find what you were looking for?